Search tips
Search criteria 


Logo of jcinvestThe Journal of Clinical InvestigationCurrent IssueArchiveSubscriptionAbout the Journal
J Clin Invest. 1981 November; 68(5): 1331–1337.
PMCID: PMC370929

Reactivity of a monoclonal antibody with human ovarian carcinoma.


A murine monoclonal antibody (OC125) has been developed that reacts with each of six epithelial ovarian carcinoma cell lines and with cryopreserved tumor tissue from 12 of 20 ovarian cancer patients. By contrast, the antibody does not bind to a variety of nonmalignant tissues, including adult and fetal ovary. OC125 reacts with only 1 of 14 cell lines derived from nonovarian neoplasms and has failed to react with cryostat sections from 12 nonovarian carcinomas.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.4M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Levi MM, Keller S, Mandl I. Antigenicity of a papillary serous cystadenocarcinoma tissue homogenate and its fractions. Am J Obstet Gynecol. 1969 Nov 15;105(6):856–861. [PubMed]
  • Gall SA, Walling J, Pearl J. Demonstration of tumor-associated antigens in human gynecologic malignancies. Am J Obstet Gynecol. 1973 Feb 1;115(3):387–393. [PubMed]
  • Knauf S, Urbach GI. Purification of human ovarian tumor-associated antigen and demonstration of circulating tumor antigen in patients with advanced ovarian malignancy. Am J Obstet Gynecol. 1977 Apr 1;127(7):705–710. [PubMed]
  • Imamura N, Takahashi T, Lloyd KO, Lewis JL, Jr, Old LJ. Analysis of human ovarian tumor antigens using heterologous antisera: detection of new antigenic systems. Int J Cancer. 1978 May 15;21(5):570–577. [PubMed]
  • Order SE, Thurnston J, Knapp R. Ovarian tumor antigens: a new potential for therapy. Natl Cancer Inst Monogr. 1975 Oct;42:33–43. [PubMed]
  • Order SE, Donahue V, Knapp R. Immunotherapy of ovarian carcinoma. An experimental model. Cancer. 1973 Sep;32(3):573–579. [PubMed]
  • Order SE, Kirkman R, Knapp R. Serologic immunotherapy: results and probable mechanism of action. Cancer. 1974 Jul;34(1):175–183. [PubMed]
  • Order SE, Rosenshein NB, Klein JL, Lichter AS, Ettinger DS, Dillon MB, Leibel SA. New methods applied to the analysis and treatment of ovarian cancer. Int J Radiat Oncol Biol Phys. 1979 Jun;5(6):861–873. [PubMed]
  • Bast RC, Jr, Knapp RC, Mitchell AK, Thurston JG, Tucker RW, Schlossman SF. Immunotherapy of a murine ovarian carcinoma with Corynebacterium parvum and specific heteroantiserum. I. Activation of peritoneal cells to mediate antibody-dependent cytotoxicity. J Immunol. 1979 Nov;123(5):1945–1951. [PubMed]
  • Young RC, Chabner BA, Hubbard SP, Fisher RI, Bender RA, Anderson T, Simon RM, Canellos GP, DeVita VT., Jr Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy. N Engl J Med. 1978 Dec 7;299(23):1261–1266. [PubMed]
  • Parker LM, Griffiths CT, Yankee RA, Canellos GP, Gelman R, Knapp RC, Richman CM, Tobias JS, Weiner RS, Frei E., 3rd Combination chemotherapy with adriamycin-cyclophosphamide for advanced ovarian carcinoma. Cancer. 1980 Aug 15;46(4):669–674. [PubMed]
  • GRAHAM JB, GRAHAM RM. Autogenous vaccine in cancer patients. Surg Gynecol Obstet. 1962 Jan;114:1–4. [PubMed]
  • Hudson CN, McHardy JE, Curling OM, English PE, Levin L, Poulton TA, Crowther M, Leighton M. Active specific immunotherapy for ovarian cancer. Lancet. 1976 Oct 23;2(7991):877–879. [PubMed]
  • Rao B, Wanebo HJ, Ochoa M, Jr, Lewis JL, Jr, Oettgen HF. Intravenous Corynebacterium parvum: an adjunct to chemotherapy for resistant advanced ovarian cancer. Cancer. 1977 Feb;39(2):514–526. [PubMed]
  • Webb HE, Oaten SW, Pike CP. Treatment of malignant ascitic and pleural effusion with Corynebacterium parvum. Br Med J. 1978 Feb 11;1(6109):338–340. [PMC free article] [PubMed]
  • Köhler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975 Aug 7;256(5517):495–497. [PubMed]
  • Bast RC, Jr, Knapp RC, Donahue VC, Thurston JG, Mitchell AK, Feeney M, Schlossman SF. Specificity of heteroantisera developed against purified populations of intact murine ovarian carcinoma cells. J Natl Cancer Inst. 1980 Feb;64(2):365–372. [PubMed]
  • Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed]
  • Chess L, MacDermott RP, Schlossman SF. Immunologic functions of isolated human lymphocyte subpopulations. I. Quantitative isolation of human T and B cells and response to mitogens. J Immunol. 1974 Oct;113(4):1113–1121. [PubMed]
  • Stashenko P, Nadler LM, Hardy R, Schlossman SF. Characterization of a human B lymphocyte-specific antigen. J Immunol. 1980 Oct;125(4):1678–1685. [PubMed]
  • Lobo PI, Westervelt FB, Horwitz DA. Identification of two populations of immunoglobulin-bearing lymphocytes in man. J Immunol. 1975 Jan;114(1 Pt 1):116–119. [PubMed]
  • Mendes NF, Tolnai ME, Silveira NP, Gilbertsen RB, Metzgar RS. Technical aspects of the rosette tests used to detect human complement receptor (B) and sheep erythrocyte-binding (T) lymphocytes. J Immunol. 1973 Sep;111(3):860–867. [PubMed]
  • Reinherz EL, Kung PC, Goldstein G, Schlossman SF. A monoclonal antibody with selective reactivity with functionally mature human thymocytes and all peripheral human T cells. J Immunol. 1979 Sep;123(3):1312–1317. [PubMed]
  • Schwaber J, Lazarus H, Rosen FS. Bone marrow-derived lymphoid cell lines from patients with agammaglobulinemia. J Clin Invest. 1978 Aug;62(2):302–310. [PMC free article] [PubMed]
  • Kennett RH, Denis KA, Tung AS, Klinman NR. Hybrid plasmacytoma production: fusions with adult spleen cells, monoclonal spleen fragments, neonatal spleen cells and human spleen cells. Curr Top Microbiol Immunol. 1978;81:77–91. [PubMed]
  • Nadler LM, Stashenko P, Hardy R, Schlossman SF. A monoclonal antibody defining a lymphoma-associated antigen in man. J Immunol. 1980 Aug;125(2):570–577. [PubMed]
  • Reinherz EL, Kung PC, Goldstein G, Levey RH, Schlossman SF. Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. Proc Natl Acad Sci U S A. 1980 Mar;77(3):1588–1592. [PubMed]
  • Nadler LM, Stashenko P, Hardy R, Pesando JM, Yunis EJ, Schlossman SF. Monoclonal antibodies defining serologically distinct HLA-D/DR related Ia-like antigens in man. Hum Immunol. 1981 Feb;2(1):77–90. [PubMed]
  • Stashenko P, Nadler LM, Hardy R, Schlossman SF. Characterization of a human B lymphocyte-specific antigen. J Immunol. 1980 Oct;125(4):1678–1685. [PubMed]
  • Bhan AK, Reinherz EL, Poppema S, McCluskey RT, Schlossman SF. Location of T cell and major histocompatibility complex antigens in the human thymus. J Exp Med. 1980 Oct 1;152(4):771–782. [PMC free article] [PubMed]
  • Colvin RB, Johnson RA, Mihm MC, Jr, Dvorak HF. Role of the clotting system in cell-mediated hypersensitivity. I. Fibrin deposition in delayed skin reactions in man. J Exp Med. 1973 Sep 1;138(3):686–698. [PMC free article] [PubMed]
  • Colvin RB, Gardner PI, Roblin RO, Verderber EL, Lanigan JM, Mosesson MW. Cell surface fibrinogen-fibrin receptors on cultured human fibroblasts. Association with fibronectin (cold insoluble globulin, LETS protein) and loss in SV40 transformed cells. Lab Invest. 1979 Nov;41(5):464–473. [PubMed]
  • van Nagell JR, Jr, Donaldson ES, Gay EC, Sharkey RM, Rayburn P, Goldenberg DM. Carcinoembryonic antigen in ovarian epithelial cystadenocarcinomas: the prognostic value of tumor and serial plasma determinations. Cancer. 1978 Jun;41(6):2335–2340. [PubMed]
  • Koprowski H, Steplewski Z, Herlyn D, Herlyn M. Study of antibodies against human melanoma produced by somatic cell hybrids. Proc Natl Acad Sci U S A. 1978 Jul;75(7):3405–3409. [PubMed]
  • Yeh MY, Hellström I, Brown JP, Warner GA, Hansen JA, Hellström KE. Cell surface antigens of human melanoma identified by monoclonal antibody. Proc Natl Acad Sci U S A. 1979 Jun;76(6):2927–2931. [PubMed]
  • Herlyn M, Steplewski Z, Herlyn D, Koprowski H. Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. Proc Natl Acad Sci U S A. 1979 Mar;76(3):1438–1442. [PubMed]
  • Tobias JS, Griffiths CT. Management of ovarian carcinoma. Current concepts and future prospects (first of two parts). N Engl J Med. 1976 Apr 8;294(15):818–822. [PubMed]
  • Reinherz EL, Nadler LM, Sallan SE, Schlossman SF. Subset derivation of T-cell acute lymphoblastic leukemia in man. J Clin Invest. 1979 Aug;64(2):392–397. [PMC free article] [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation